Alkermes (STU:8AK) Current Accrued Expense : €297 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Alkermes Current Accrued Expense?

Alkermes's Current Accrued Expense for the quarter that ended in Mar. 2024 was €297 Mil.

Alkermes's quarterly Current Accrued Expense increased from Sep. 2023 (€306 Mil) to Dec. 2023 (€326 Mil) but then declined from Dec. 2023 (€326 Mil) to Mar. 2024 (€297 Mil).

Alkermes's annual Current Accrued Expense increased from Dec. 2021 (€277 Mil) to Dec. 2022 (€340 Mil) but then declined from Dec. 2022 (€340 Mil) to Dec. 2023 (€326 Mil).

Alkermes Current Accrued Expense Historical Data

The historical data trend for Alkermes's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkermes Current Accrued Expense Chart

Alkermes Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

222.03

242.46

276.77

340.10

325.94

Alkermes Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															361.99	296.39	306.33	325.94	296.67

Alkermes Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Alkermes Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Alkermes's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Alkermes (STU:8AK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkermes PLC (STU:8AK) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

ALKS:USA 8AK:Germany

Address

1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6

Website

https://www.alkermes.com

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.

Alkermes (STU:8AK) Headlines

No Headlines